Approval · Notice of Compliance 31586 · 2023
UCERIS: Notice of Compliance 31586
Issued September 8, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31586
- Date
- September 8, 2023
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing and primary packaging site for a metered dose drug product.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| UCERIS | Not yet assigned | — |
Medicinal ingredients
- BUDESONIDE 20 MG per DOSE